Treatment of Severe Atopic Dermatitis (AD)
A new area of treatment options makes it possible to choose evidence-based drugs with a more favorable risk/benefit profile for patients with atopic dermatitis. According to Dr. Pedro Mendes-Bastos, we first must select the right, and most severely affected, patients. Secondly, we are to choose between drugs. Get his elaboration in this EADV 2022 MEDtalk.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in